BullFrog AI Holdings (BFRGW) Net Cash Flow (2022 - 2025)
BullFrog AI Holdings' (BFRGW) quarterly Net Cash Flow came in at $192993.0 in Q4 2025, down 83.88% on a YoY basis from $1.2 million in Q4 2024, and up 139.96% quarter-over-quarter from -$482923.0 in Q3 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Net Cash Flow (2022 - 2025) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Net Cash Flow for 4 consecutive years, with $192993.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow fell 83.88% year-over-year to $192993.0; the trailing twelve-month figure through Dec 2025 stood at -$3.1 million (down 211.95% YoY), and the FY2025 full-year result was -$3.1 million, down 211.95% from the prior year.
- Net Cash Flow climbed to $192993.0 in Q4 2025 per BFRGW's latest filing, from -$482923.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $5.4 million in Q1 2023 and bottomed at -$1.6 million in Q1 2025.
- Historically, Net Cash Flow has averaged $142964.7 across 4 years, with a median of -$91131.0 in 2022.
- The widest YoY moves for Net Cash Flow: up 38267.45% in 2023, down 8067.56% in 2023.
- Over 4 years, Net Cash Flow stood at $15454.0 in 2022, then sank by 8067.56% to -$1.2 million in 2023, then surged by 197.21% to $1.2 million in 2024, then sank by 83.88% to $192993.0 in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered $192993.0, -$482923.0, and -$1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.13 Bn | 198.14 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | -4.43 Bn |
| 3 | Vertex Pharmaceuticals | 132.34 Bn | 124.49 Bn | 2.84 Bn | 652.90 Mn |
| 4 | Regeneron Pharmaceuticals | 82.70 Bn | 74.71 Bn | 3.93 Bn | -504.30 Mn |
| 5 | Argenx Se | 61.60 Bn | 56.42 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.61 Bn | 49.48 Bn | 52.00 Mn | -183.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.96 Bn | 30.65 Bn | 992.69 Mn | -496,000.00 |
| 8 | Biogen | 31.26 Bn | 29.97 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 29.96 Bn | 29.96 Bn | 1.16 Mn | -170.75 Mn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 192,993.00 |
| Sep 30, 2025 | -482,923.00 |
| Jun 30, 2025 | -1.22 Mn |
| Mar 31, 2025 | -1.63 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | -1.38 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | 4.39 Mn |
| Dec 31, 2023 | -1.23 Mn |
| Sep 30, 2023 | -1.60 Mn |
| Jun 30, 2023 | 40,048.00 |
| Mar 31, 2023 | 5.36 Mn |
| Dec 31, 2022 | 15,454.00 |
| Sep 30, 2022 | -196,237.00 |
| Jun 30, 2022 | 223,208.00 |
| Mar 31, 2022 | 13,975.00 |